510(k) K261380
K261380 is an FDA 510(k) premarket notification submitted by Proscia, Inc. for the device "Concentriq AP-Dx". The FDA issued a decision of Substantially Equivalent on August 5, 2026. The device falls under product code QKQ (Digital Pathology Image Viewing And Management Software), a Class II device regulated under 21 CFR 864.3700. Proscia, Inc. has at least 1 other 510(k) clearance on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 5, 2026
- Date Received
- April 27, 2026
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Digital Pathology Image Viewing And Management Software
- Device Class
- Class II
- Regulation Number
- 864.3700
- Review Panel
- PA
- Submission Type
Digital pathology image viewing and management software device is a software intended for viewing and management of digital images of scanned surgical pathology slides prepared from formalin-fixed paraffin embedded (FFPE) tissue. It is an aid to the pathologist to review and interpret these digital images for the purposes of primary diagnosis.